Related Experiment Video
Updated: May 23, 2026
09:43
Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
Published on: October 5, 2021
Can we teach an old drug new tricks?
Jun-Hong Ch'ng1, Laurent Renia, Francois Nosten
1Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. chngjunhong@hotmail.com
Trends in Parasitology
|March 27, 2012
Summary
Higher doses of chloroquine (CQ) may offer a new malaria treatment strategy by triggering a distinct parasite cell death pathway. This approach could overcome CQ resistance and reduce adverse effects.
Area of Science:
- Malariology
- Drug Discovery
- Parasitology
Background:
- Chloroquine (CQ) resistance in Plasmodium falciparum malaria has limited its therapeutic use.
- Established CQ antimalarial mechanisms operate at nanomolar drug concentrations.
Purpose of the Study:
- To investigate the potential of higher chloroquine (CQ) doses in overcoming malaria parasite resistance.
- To explore a distinct cell death pathway induced by micromolar CQ concentrations.
Main Methods:
- The study examines the effects of CQ at micromolar concentrations on Plasmodium falciparum.
- Analysis focuses on the mechanism of parasite cell death and digestive vacuole integrity.
Main Results:
- Micromolar CQ levels induce a unique cell death pathway distinct from nanomolar mechanisms.
- This pathway involves digestive vacuole permeabilization and hydrolytic enzyme release.
Conclusions:
- The identified CQ-induced cell death pathway presents a promising antimalarial strategy.
- Revising CQ treatment regimens to achieve higher blood levels may be effective against resistant malaria strains without increasing toxicity.
Related Concept Videos
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:17Classical Conditioning in Daily Life
Classical conditioning, a fundamental principle of associative learning, explains various phenomena observed in daily life, such as fear development, the placebo effect, taste aversion, and drug habituation. These applications demonstrate the profound impact of associative learning on human behavior and physiological responses.
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...